New COVID-19 test to differentiate between lethal and non-lethal infections

摘要

A ground-breaking test for the potentially fatal COVID-19 strain of coronavirus is available at global health diagnostics company Randox Laboratories.The test,developed on Randox's patented Biochip Technology,is as an enhanced multiplex array which includes tests for COVID-19 and nine other respiratory viruses which can display the same symptoms.The new enhanced Biochip therefore allows clinicians to quickly and efficiently differentiate between potentially lethal and non-lethal infections.